These findings underscore the complex and imbalanced nature of CP-CIDs, where energy and oxidative stress imbalances may drive carcinogenesis, while NCP-CIDs appear to maintain a dynamic equilibrium that mitigates cancer risk. The gene discussed is CP; the disease is cancer.